The latest financial statement is for the quarter ending 2025-10-31.
| Cash Flow | 2025-10-31 | 2025-07-31 | 2025-04-30 | 2025-01-31 |
|---|---|---|---|---|
| Net loss (including amounts attributable to redeemable non-controlling interests) | -35,800 | -27,763 | -35,641 | -17,064 |
| Stock-based compensation | 37,828 | 37,555 | 30,643 | 27,956 |
| Amortization of deferred contract costs | 10,481 | 10,030 | 9,421 | 9,010 |
| Depreciation and amortization | 5,987 | 4 | 2,606 | 7,989 |
| Provision for credit losses | 48 | 368 | 232 | 174 |
| Value of common stock donated to charity | 672 | 751 | 1,109 | 1,012 |
| (accretion) amortization of (discount) premium on marketable securities | -168 | -255 | -399 | -474 |
| Non-cash foreign exchange (gain) loss | - | - | - | 1,033 |
| Non-cash foreign exchange loss | 398 | 18 | -1,029 | - |
| Fair value adjustments to contingent consideration | 0 | 0 | 223 | 223 |
| Fixed asset write off | - | - | - | 488 |
| Fixed asset write offs | -398 | - | - | - |
| Other | 28 | -28 | -271 | 153 |
| Accounts receivable | 2,050 | -2,441 | -9,108 | 5,136 |
| Prepaid expenses and other current assets | -2,927 | -1,889 | -3,147 | 5,264 |
| Deferred contract costs | 14,401 | 12,944 | 11,870 | 13,407 |
| Rou assets and liabilities | 320 | -96 | 410 | 184 |
| Other assets | 416 | 8,048 | 403 | -477 |
| Accounts payable | 2,514 | -181 | -978 | -586 |
| Accrued expenses and other current liabilities | 4,715 | 8,421 | -7,203 | 1,589 |
| Deferred revenue | 9,470 | -10,054 | 24,547 | 16,370 |
| Other long-term liabilities | -132 | -121 | -1 | 195 |
| Net cash provided by operating activities | 20,967 | 6,952 | 24,144 | 17,083 |
| Cash paid for acquisition, net of cash acquired | 689 | 181,200 | - | 0 |
| Purchases of property and equipment | 1,942 | 2,609 | 217 | 1,087 |
| Capitalized internal-use software costs | 1,246 | 810 | 1,055 | 791 |
| Purchases of marketable securities | 36,804 | 22,751 | 52,364 | 38,430 |
| Maturities of marketable securities | 34,959 | 39,325 | 63,215 | 36,267 |
| Return of principal on marketable securities | -9 | 7,495 | 113,258 | 3,200 |
| Net cash used in investing activities | -5,731 | -160,550 | 122,837 | -841 |
| Proceeds from exercise of common stock options | 1,082 | 2,596 | 605 | 3,224 |
| Proceeds from stock associated with employee stock purchase plan | 0 | 4,882 | - | 2,953 |
| Payments of deferred purchase consideration | 0 | 0 | 0 | 0 |
| Net cash provided by financing activities | 1,082 | 7,478 | 605 | 6,177 |
| Effect of foreign currency exchange rate changes on cash, cash equivalents, and restricted cash | -207 | -209 | 851 | -669 |
| Net change in cash, cash equivalents, and restricted cash | 16,111 | -146,329 | 148,437 | 21,750 |
| Cash and cash equivalents at beginning of period | 83,592 | - | - | - |
| Cash and cash equivalents at end of period | 101,811 | - | - | - |
Braze, Inc. (BRZE)
Braze, Inc. (BRZE)